As summarized in Table 1, several patient tumors and cancer cell lines display upregulated expression of SR-BI relative to healthy tissue, rendering SR-BI an interesting cell-surface receptor to pursue for targeted cancer therapy and imaging. This evidence concerns the gene SCARB1 and cancer.